chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Urinary tract infection, Vaccination site erythema
Clinical narrative: Felt like she had an UTI; Pain; Sore arm, arm is killing her; Red mark at injection site; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches). At the time of the report, URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 years of age, were inadvertently administered the Moderna COVID-19 Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 Vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 Vaccine). On 03-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 Vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient did not experience any adverse event symptoms and no treatment was administered.  This report refers to a case of product administered to patient of inappropriate age, for mRNA-1273, lot #: 016B21A,  with no associated AEs.   This case was linked to US-MODERNATX, INC.-MOD-2021-067510, US-MODERNATX, INC.-MOD-2021-067198, US-MODERNATX, INC.-MOD-2021-067547, US-MODERNATX, INC.-MOD-2021-067645, US-MODERNATX, INC.-MOD-2021-067217 (E2B Linked Report).; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age, for mRNA-1273, lot #: 016B21A,  with no associated AEs. US-MODERNATX, INC.-MOD-2021-067510:Crosslinked cases US-MODERNATX, INC.-MOD-2021-067198:Crosslinked cases US-MODERNATX, INC.-MOD-2021-067547:Crosslinked cases US-MODERNATX, INC.-MOD-2021-067645:Crosslinked cases US-MODERNATX, INC.-MOD-2021-067217:Crosslinked cases
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Tinnitus
Clinical narrative: Fatigue; ringing in both ears; Arm  was sore; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS, PAIN IN EXTREMITY, and FATIGUE in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020b21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced TINNITUS and PAIN IN EXTREMITY. On 01-Apr-2021, the patient experienced FATIGUE. On 01-Apr-2021, FATIGUE had resolved. On 02-Apr-2021, PAIN IN EXTREMITY had resolved. At the time of the report, TINNITUS had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 31-Mar-2021, at 7:30 am, the patient received first dose of vaccine in left non-dominate arm.  No concomitant medications were reported. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vaccination site pain
Clinical narrative: diarrhea on and off; soreness at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea on and off) and VACCINATION SITE PAIN (soreness at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE, ATORVASTATIN, LISINOPRIL, SERTRALINE, GLIMEPIRIDE, PIOGLITAZONE, PANTOPRAZOLE, FLUTICASONE PROPIONATE (FLONASE) and TRAZODONE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea on and off) and VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, DIARRHOEA (diarrhea on and off) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient contacted her primary care physician regarding her symptoms. Treatment for the events included, Loperamide, Tylenol (Acetaminophen), and ice.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Vaccination site erythema, Vaccination site mass, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warm to the touch; can feel the lump of the swollen tissue; very hot to touch; swelling on her arm at the injection site; some redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE MASS (can feel the lump of the swollen tissue), FEELING HOT (very hot to touch), VACCINATION SITE SWELLING (swelling on her arm at the injection site) and VACCINATION SITE ERYTHEMA (some redness at the injection site) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concomitant products included ETONOGESTREL (NEXPLANON) for Birth control.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE MASS (can feel the lump of the swollen tissue), FEELING HOT (very hot to touch), VACCINATION SITE SWELLING (swelling on her arm at the injection site) and VACCINATION SITE ERYTHEMA (some redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE MASS (can feel the lump of the swollen tissue), FEELING HOT (very hot to touch), VACCINATION SITE SWELLING (swelling on her arm at the injection site) and VACCINATION SITE ERYTHEMA (some redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medications were given.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Induration, Pain, Skin mass, Urticaria
Clinical narrative: Bumps; Hives; Bumps/hives that are hard; Bumps/hives that are painful; This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (Bumps), URTICARIA (Hives), INDURATION (Bumps/hives that are hard) and PAIN (Bumps/hives that are painful) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included ROSUVASTATIN and CARBAMAZEPINE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced SKIN MASS (Bumps), URTICARIA (Hives), INDURATION (Bumps/hives that are hard) and PAIN (Bumps/hives that are painful). At the time of the report, SKIN MASS (Bumps), URTICARIA (Hives), INDURATION (Bumps/hives that are hard) and PAIN (Bumps/hives that are painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The hives occurred on the back of his neck and on the right side of the chest. The hives on his chest seem to have improved, but not by much.  Treatment for the events included cortisone cream.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: a triangular rash very itchy on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (a triangular rash very itchy on her left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (survivor of 22 years.).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced RASH PRURITIC (a triangular rash very itchy on her left arm). At the time of the report, RASH PRURITIC (a triangular rash very itchy on her left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No other relevant concomitant medication were reported. No treatment information were reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: TCR : AE details and event outcome details were updated as recovered/Resolved
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Erythema, Infection, Myalgia
Clinical narrative: scrape on hand got all swelled up; scrape on hand turn red; scrape on hand infected; joint soreness; muscle soreness; swelling all over; hard time breathing; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling all over), DYSPNOEA (hard time breathing), PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hand injury (Patient had scrape on his hand that was 6 inches long and it was healing.).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced SWELLING (swelling all over), DYSPNOEA (hard time breathing), ARTHRALGIA (joint soreness) and MYALGIA (muscle soreness). On an unknown date, the patient experienced PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected). At the time of the report, SWELLING (swelling all over), DYSPNOEA (hard time breathing), ARTHRALGIA (joint soreness) and MYALGIA (muscle soreness) was resolving and PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling
Clinical narrative: scrape on hand got all swelled up; scrape on hand turn red; scrape on hand infected; joint soreness; muscle soreness; swelling all over; hard time breathing; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling all over), DYSPNOEA (hard time breathing), PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hand injury (Patient had scrape on his hand that was 6 inches long and it was healing.).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced SWELLING (swelling all over), DYSPNOEA (hard time breathing), ARTHRALGIA (joint soreness) and MYALGIA (muscle soreness). On an unknown date, the patient experienced PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected). At the time of the report, SWELLING (swelling all over), DYSPNOEA (hard time breathing), ARTHRALGIA (joint soreness) and MYALGIA (muscle soreness) was resolving and PERIPHERAL SWELLING (scrape on hand got all swelled up), ERYTHEMA (scrape on hand turn red) and INFECTION (scrape on hand infected) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling, Swelling
Clinical narrative: pain in left side; bump in left arm; lump on neck; pain radiating on the left side up her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left side), PERIPHERAL SWELLING (bump in left arm), SWELLING (lump on neck) and PAIN (pain radiating on the left side up her neck) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in left side), PERIPHERAL SWELLING (bump in left arm), SWELLING (lump on neck) and PAIN (pain radiating on the left side up her neck). At the time of the report, PAIN IN EXTREMITY (pain in left side), PERIPHERAL SWELLING (bump in left arm), SWELLING (lump on neck) and PAIN (pain radiating on the left side up her neck) had not resolved.            Patient used ibuprofen for treatment. No concomitant medication was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rotator cuff syndrome
Clinical narrative: inflammation in her rotator cuff; left arm got sore right away; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (left arm got sore right away) and ROTATOR CUFF SYNDROME (inflammation in her rotator cuff) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm got sore right away). On an unknown date, the patient experienced ROTATOR CUFF SYNDROME (inflammation in her rotator cuff). At the time of the report, PAIN IN EXTREMITY (left arm got sore right away) and ROTATOR CUFF SYNDROME (inflammation in her rotator cuff) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or medical history provided. Patient states she received an oral steroid taper 2 weeks after 1st shot.   This case was linked to US-MODERNATX, INC.-MOD-2021-067275 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067275:Dose 2
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Eye pain, Feeling abnormal, Influenza like illness
Clinical narrative: difficulty breathing; eye started hurting; pressure in her right eye was higher; felt like she was having flu; strange feeling like she was going to have some kind of illness coming; had chills for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu) and FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M23A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided) since an unknown date.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu), FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) and CHILLS (had chills for 2-3 days). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu), FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) and CHILLS (had chills for 2-3 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular discomfort
Clinical narrative: difficulty breathing; eye started hurting; pressure in her right eye was higher; felt like she was having flu; strange feeling like she was going to have some kind of illness coming; had chills for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu) and FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M23A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided) since an unknown date.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu), FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) and CHILLS (had chills for 2-3 days). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, DYSPNOEA (difficulty breathing), EYE PAIN (eye started hurting), OCULAR DISCOMFORT (pressure in her right eye was higher), INFLUENZA LIKE ILLNESS (felt like she was having flu), FEELING ABNORMAL (strange feeling like she was going to have some kind of illness coming) and CHILLS (had chills for 2-3 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17-year-old sister who received the Moderna COVID19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old sister who received the Moderna COVID19 Vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old sister who received the Moderna COVID19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old sister who received the Moderna COVID19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD21-069858, US-MODERNATX, INC.-MOD-2021-067318 (E2B Linked Report).; Sender's Comments:  MOD21-069858: US-MODERNATX, INC.-MOD-2021-067318:Brother case
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 47 days past the first dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (47 days past the first dose of vaccine) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical reported history).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (47 days past the first dose of vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (47 days past the first dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported.   It was noted that the patient did not have any symptoms following the vaccination. She did not receive any treatment.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID 19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (COVID 19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID 19). At the time of the report, COVID-19 (COVID 19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided. Patient received treatment.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: both arms are sore; Hard to put her clothes on; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on). At the time of the report, PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or medical history provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067270 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067270:Dose 1
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity, Rash
Clinical narrative: a little soreness of the arm; bad rash all over his body including upper thighs, lower back, from his ankles to not quite his knees, and fingers; redness at the injection site; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (bad rash all over his body including upper thighs, lower back, from his ankles to not quite his knees, and fingers), PAIN IN EXTREMITY (a little soreness of the arm), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (Swelling at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (Swelling at the injection site). On 17-Mar-2021, the patient experienced RASH (bad rash all over his body including upper thighs, lower back, from his ankles to not quite his knees, and fingers). On an unknown date, the patient experienced PAIN IN EXTREMITY (a little soreness of the arm). On 12-Mar-2021, INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (Swelling at the injection site) had resolved. At the time of the report, RASH (bad rash all over his body including upper thighs, lower back, from his ankles to not quite his knees, and fingers) was resolving and PAIN IN EXTREMITY (a little soreness of the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient's HCP advised him to take OTC diphenhydramine and prescribed a course of prednisone.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant after 1st dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Mar-2021 and the estimated date of delivery was 08-Dec-2021. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 03-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Due date was reported as Dec 2021.
Sex: F
Vaccine: COVID19
Symptoms: Vulvovaginal pruritus
Clinical narrative: itching on the vagina; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Apr-2021 and was forwarded to Moderna on 05-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VULVOVAGINAL PRURITUS (itching on the vagina) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event (No medical history or known allergies reported.).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VULVOVAGINAL PRURITUS (itching on the vagina). At the time of the report, VULVOVAGINAL PRURITUS (itching on the vagina) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant or treatment medications reported. Reporter did not provide any other information regarding events and hung up the phone before any other information could be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Breast swelling, Burning sensation, Fatigue, Lymphadenopathy
Clinical narrative: low grade fever; very weak, I started feeling somewhat better as far as energy; sometimes it feels like my left breast still has swelling; swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast; mild fatigue/very tired; burning sensation at the site of the injection on her left arm; pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation at the site of the injection on her left arm), PAIN IN EXTREMITY (pain in the left arm), PYREXIA (low grade fever), ASTHENIA (very weak, I started feeling somewhat better as far as energy) and BREAST SWELLING (sometimes it feels like my left breast still has swelling) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism since 1999. Concomitant products included LEVOTHYROXINE from 1999 to an unknown date for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced BURNING SENSATION (burning sensation at the site of the injection on her left arm), PAIN IN EXTREMITY (pain in the left arm) and FATIGUE (mild fatigue/very tired). On 01-Apr-2021 at 11:00 PM, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast). On an unknown date, the patient experienced PYREXIA (low grade fever), ASTHENIA (very weak, I started feeling somewhat better as far as energy) and BREAST SWELLING (sometimes it feels like my left breast still has swelling). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 02-Apr-2021, PAIN IN EXTREMITY (pain in the left arm) had resolved. On 08-Apr-2021, LYMPHADENOPATHY (swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast) had resolved with sequelae. At the time of the report, BURNING SENSATION (burning sensation at the site of the injection on her left arm), PYREXIA (low grade fever) and BREAST SWELLING (sometimes it feels like my left breast still has swelling) outcome was unknown and ASTHENIA (very weak, I started feeling somewhat better as far as energy) and FATIGUE (mild fatigue/very tired) was resolving.            Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received on 04-AUG-2021, New events added & event outcome updated, Patient Medical history information updated, Vaccine Facility Information Updated.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: low grade fever; very weak, I started feeling somewhat better as far as energy; sometimes it feels like my left breast still has swelling; swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast; mild fatigue/very tired; burning sensation at the site of the injection on her left arm; pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation at the site of the injection on her left arm), PAIN IN EXTREMITY (pain in the left arm), PYREXIA (low grade fever), ASTHENIA (very weak, I started feeling somewhat better as far as energy) and BREAST SWELLING (sometimes it feels like my left breast still has swelling) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism since 1999. Concomitant products included LEVOTHYROXINE from 1999 to an unknown date for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced BURNING SENSATION (burning sensation at the site of the injection on her left arm), PAIN IN EXTREMITY (pain in the left arm) and FATIGUE (mild fatigue/very tired). On 01-Apr-2021 at 11:00 PM, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast). On an unknown date, the patient experienced PYREXIA (low grade fever), ASTHENIA (very weak, I started feeling somewhat better as far as energy) and BREAST SWELLING (sometimes it feels like my left breast still has swelling). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 02-Apr-2021, PAIN IN EXTREMITY (pain in the left arm) had resolved. On 08-Apr-2021, LYMPHADENOPATHY (swollen lymph nodes in left arm/ My lymph nodes were very swollen on my left upper arm and my left breast) had resolved with sequelae. At the time of the report, BURNING SENSATION (burning sensation at the site of the injection on her left arm), PYREXIA (low grade fever) and BREAST SWELLING (sometimes it feels like my left breast still has swelling) outcome was unknown and ASTHENIA (very weak, I started feeling somewhat better as far as energy) and FATIGUE (mild fatigue/very tired) was resolving.            Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received on 04-AUG-2021, New events added & event outcome updated, Patient Medical history information updated, Vaccine Facility Information Updated.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain, Vaccination site swelling
Clinical narrative: developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.; minor pain at site after about 3 hrs; swelling at site after about 3 hrs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Aching in knees and Stomachache. Concurrent medical conditions included Heart disorder. Concomitant products included METOPROLOL for Heart disorder, SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO), LEVOTHYROXINE SODIUM (SYNTHROID), SPIRONOLACTONE (ALDACTONE A) and FAMOTIDINE (PEPCID AC) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs). At the time of the report, RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication information  was not provided  by the reporter. Medical history included Back , knees , stomach not specified.   This case was linked to MOD-2021-060863 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up document received on 15-JUL-2021 contains new information of event updated, outcome updated, medical history and  concomitant medication information updated
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash on her arm). At the time of the report, RASH (Rash on her arm) had not resolved.            No concomitant medication was reported. The treatment information was unknown. On Sunday 04Apr21 at night time the rash came  back and is still there. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage patient received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage patient received the vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage patient received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage patient received the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided. Treatment information was not available.; Sender's Comments: This report refers to a case of Product administered to patient of inappropriate age, for mRNA-1273, lot #: 041L20A, with no associated AEs.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and COVID-19 (tested positive for COVID) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation and Seizure. Concomitant products included TEMAZEPAM (RESTORIL [TEMAZEPAM]) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2. On 28-Mar-2021, the patient experienced COVID-19 (tested positive for COVID). On an unknown date, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication use included blood pressure medication, seizure medication and Tylenol.    Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Patient Denied further follow up, took second dose
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Skin reaction, Skin warm
Clinical narrative: biceps and triceps area red and warm; upper biceps and triceps area red and warm; 2 lines going down in the arm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (biceps and triceps area red and warm), ERYTHEMA (upper biceps and triceps area red and warm) and SKIN REACTION (2 lines going down in the arm) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced SKIN WARM (biceps and triceps area red and warm), ERYTHEMA (upper biceps and triceps area red and warm) and SKIN REACTION (2 lines going down in the arm). At the time of the report, SKIN WARM (biceps and triceps area red and warm), ERYTHEMA (upper biceps and triceps area red and warm) and SKIN REACTION (2 lines going down in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Jaw disorder, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swollen at the injection site; Red at the injection site; Left jaw felt weird; This spontaneous case was reported by an other and describes the occurrence of JAW DISORDER (Left jaw felt weird), VACCINATION SITE ERYTHEMA (Red at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included Lupus erythematosus systemic since an unknown date. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), ACETYLSALICYLIC ACID (ASPIRIN 81) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.    On 26-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 03-Apr-2021, the patient experienced JAW DISORDER (Left jaw felt weird). On 04-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red at the injection site). On 05-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swollen at the injection site). At the time of the report, JAW DISORDER (Left jaw felt weird), VACCINATION SITE ERYTHEMA (Red at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) outcome was unknown.            Concomitant medication of cholesterol medication is stated in report.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Type IV hypersensitivity reaction
Clinical narrative: Covid arm; Arm hurts him something terrible; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Covid arm) and PAIN IN EXTREMITY (Arm hurts him something terrible) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for an unknown indication.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Covid arm) and PAIN IN EXTREMITY (Arm hurts him something terrible).            This case was linked to US-MODERNATX, INC.-MOD-2021-067368 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067368:cross linked case